Immunoglobulin A Vasculitis in a Japanese Patient with Complete Familial Mediterranean Fever Carrying MEFV Exon 10 Mutation.

Immunoglobulin A (IgA) vasculitis is a systemic small-vessel vasculitis involving the skin, kidney, joints, and gastrointestinal tract. Familial Mediterranean fever (FMF) is the most common autoinflammatory disease characterized by periodic fever, peritonitis, pleuritis, or arthritis. It is well known that FMF may coexist with vasculitis, especially small and medium vessel vasculitis. Here we present a Japanese male patient with FMF who later developed IgA vasculitis and a relapsing disease course. A 51-year-old Japanese male was referred because of upper abdominal pain, arthralgia, and bilateral purpura of the lower limbs. He fulfilled the criteria for IgA vasculitis, which was successfully treated by corticosteroid and immunosuppressive therapy. He had a medical history of periodic fever since the age of 10 years old. The Mediterranean fever (MEFV) gene analysis revealed that he was heterozygous for M694I and E148Q mutations. Colchicine therapy resolved his periodic febrile attacks. To our knowledge, coexistence of FMF with IgA vasculitis has not been reported in East Asia, including Japan. Our case suggests that MEFV gene exon 10 mutations could be related to the development of IgA vasculitis and affects its clinical course.

[1]  Xiao‐Kang Li,et al.  The Role of Immune Modulation in Pathogenesis of IgA Nephropathy , 2020, Frontiers in Medicine.

[2]  S. Özen,et al.  Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients. , 2020, Rheumatology.

[3]  Hee-Jae Jung,et al.  Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review. , 2019, Journal of autoimmunity.

[4]  B. Armağan,et al.  Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study , 2019, Rheumatology International.

[5]  D. Kastner,et al.  The Pyrin Inflammasome in Health and Disease , 2019, Front. Immunol..

[6]  D. Saadoun,et al.  Association of Vasculitis and Familial Mediterranean Fever , 2019, Front. Immunol..

[7]  E. Çakıcı,et al.  MEFV gene mutations in children with Henoch–Schönlein purpura and their correlations—do mutations matter? , 2019, Clinical Rheumatology.

[8]  M. Yılmaz,et al.  MEFV gene variants in children with Henoch-Schönlein purpura and association with clinical manifestations: a single-center Mediterranean experience , 2018, Postgraduate medicine.

[9]  R. Salomon,et al.  Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  T. Wada,et al.  Longitudinal analysis of serum interleukin‐18 in patients with familial Mediterranean fever carrying MEFV mutations in exon 10 , 2017, Cytokine.

[11]  A. Belot,et al.  Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome , 2018, Rheumatology.

[12]  A. Jamin,et al.  New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura). , 2017, Autoimmunity reviews.

[13]  S. Özen,et al.  Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management , 2017, Front. Immunol..

[14]  S. Yamasaki,et al.  Familial Mediterranean fever is no longer a rare disease in Japan , 2016, Arthritis Research & Therapy.

[15]  K. Yoshiura,et al.  Multiple Serum Cytokine Profiling to Identify Combinational Diagnostic Biomarkers in Attacks of Familial Mediterranean Fever , 2016, Medicine.

[16]  S. Amselem,et al.  Vasculitis associated with familial Mediterranean fever: a study on 16 french adult cases , 2015, Pediatric Rheumatology.

[17]  E. Thervet,et al.  IgA vasculitis (Henoch-Shönlein purpura) in adults: Diagnostic and therapeutic aspects. , 2015, Autoimmunity reviews.

[18]  D. Kapoor,et al.  Levels of Interleukin‐18 and Endothelin‐1 in Children with Henoch‐Schönlein Purpura: A Study from Northern India , 2013, Pediatric dermatology.

[19]  D. Kastner,et al.  Lighting the fires within: the cell biology of autoinflammatory diseases , 2012, Nature Reviews Immunology.

[20]  N. Shan,et al.  Imbalance of Interleukin-18 and Interleukin-18 Binding Protein in Children with Henoch-Schönlein Purpura , 2011, The Journal of international medical research.

[21]  M. Bülbül,et al.  Prevalence of MEFV gene mutations and their clinical correlations in Turkish children with Henoch–Schönlein purpura , 2011, Acta paediatrica.

[22]  K. Aksu,et al.  Coexistence of vasculitides with Familial Mediterranean Fever , 2011, Rheumatology International.

[23]  M. González-Gay,et al.  IL-18 gene polymorphisms in Henoch-Schönlein purpura. , 2010, Clinical and experimental rheumatology.

[24]  F. Yalçınkaya,et al.  MEFV Mutations Modify the Clinical Presentation of Henoch-Schönlein Purpura , 2008, The Journal of Rheumatology.

[25]  N. Kamatani,et al.  Familial Mediterranean fever in three Japanese patients, and a comparison of the frequency of MEFV gene mutations in Japanese and Mediterranean populations , 2008, Modern rheumatology.

[26]  D. Booth,et al.  Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. , 2006, Rheumatology.

[27]  B. Sancak,et al.  Serum interleukin 17 and interleukin 18 levels in familial Mediterranean fever. , 2005, Clinical and experimental rheumatology.

[28]  D. Zemer,et al.  Criteria for the diagnosis of familial Mediterranean fever. , 1997, Arthritis and rheumatism.

[29]  M. Elder The Role of Cytokines , 1997 .

[30]  A. Bakkaloğlu,et al.  The role of cytokines in Henoch Schonlein purpura. , 1997, Scandinavian journal of rheumatology.

[31]  E. Sohar,et al.  Familial Mediterranean fever. , 1955, Klinische Padiatrie.